Cargando…

Prognostic and predictive impact of creatine kinase level in non-small cell lung cancer treated with tyrosine kinase inhibitors

BACKGROUND: The use of tyrosine kinase inhibitors (TKIs) is associated with incident creatine kinase (CK) elevation in the treatment of advanced non-small cell lung cancer (NSCLC) patients. However, whether higher CK levels are associated with better antitumor responses or survival remains to be exp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yu, Su, Zixuan, Lin, Yuechun, Xiong, Yaming, Li, Caichen, Li, Jianfu, Wang, Runchen, Zhong, Ran, Cheng, Bo, He, Jianxing, Xie, Zhanhong, Liang, Wenhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512461/ https://www.ncbi.nlm.nih.gov/pubmed/34733627 http://dx.doi.org/10.21037/tlcr-21-600

Ejemplares similares

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
por: Li, Feng, et al.
Publicado: (2021)

Non-small cell lung cancer with MET exon 14 skipping alteration responding to immunotherapy: a case report
por: Chen, Zhuxing, et al.
Publicado: (2021)

The creatine kinase system and pleiotropic effects of creatine
por: Wallimann, Theo, et al.
Publicado: (2011)

The impact of adjuvant EGFR-TKIs and 14-gene molecular assay on stage I non–small cell lung cancer with sensitive EGFR mutations
por: Jiang, Yu, et al.
Publicado: (2023)

Aspirin and risk of different cancers: an umbrella meta-analysis
por: Jiang, Yu, et al.
Publicado: (2020)

Lung cancers and pulmonary nodules detected by computed tomography scan: a population-level analysis of screening cohorts
por: Li, Caichen, et al.
Publicado: (2021)

Feasibility and safety of PD-1/L1 inhibitors for non-small cell lung cancer in front-line treatment: a Bayesian network meta-analysis
por: Liang, Hengrui, et al.
Publicado: (2020)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Tyrosine Kinase Inhibitors and Pregnancy
por: Abruzzese, Elisabetta, et al.
Publicado: (2014)

Nanomedicine of tyrosine kinase inhibitors
por: Smidova, Veronika, et al.
Publicado: (2021)

Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors
por: Lyu, Jiahua, et al.
Publicado: (2023)

Prognostic effect of comorbidities in patients with chronic myeloid leukemia treated with a tyrosine kinase inhibitor
por: Ono, Takaaki, et al.
Publicado: (2020)

Effect of SNPs on Creatine Kinase Structure and Function: Identifying Potential Molecular Mechanisms for Possible Creatine Kinase Deficiency Diseases
por: Li, Chang, et al.
Publicado: (2012)

The Use of Bruton’s Tyrosine Kinase Inhibitors to Treat Allergic Disorders
por: Dispenza, Melanie C.
Publicado: (2021)

Management for Residual Ground-Glass Opacity Lesions After Resection of Main Tumor in Multifocal Lung Cancer: A Case Report and Literature Review
por: Cheng, Bo, et al.
Publicado: (2021)

Creatine kinase in ischemic and inflammatory disorders
por: Kitzenberg, David, et al.
Publicado: (2016)

Creatine Kinase and Mortality in Peritoneal Dialysis
por: Wu, Xianfeng, et al.
Publicado: (2022)

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
por: Xia, Yu, et al.
Publicado: (2017)

Hydroxychloroquine: Myopathy with elevated creatine kinase and creatine kinase-MB following off-label use: case report
Publicado: (2021)

Cancer risk in heart or lung transplant recipients: A comprehensive analysis of 21 prospective cohorts
por: Ge, Fan, et al.
Publicado: (2020)

Concealed driver in lung adenocarcinoma with single PIK3CA mutation: a case report and single-center genotyping review
por: Zhu, Feng, et al.
Publicado: (2021)

Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer
por: Wu, Xiangrong, et al.
Publicado: (2022)

Gout and susceptibility and severity of COVID-19: A bidirectional Mendelian randomization analysis
por: Peng, Haoxin, et al.
Publicado: (2022)

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors
por: Cho, Daniel C
Publicado: (2013)

The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors
por: Kim, Hyungjin, et al.
Publicado: (2017)

Prognostic significance of pseudocapsule status in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors
por: Xi, Wei, et al.
Publicado: (2021)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Prognostic significance of psoas muscle index in male hepatocellular carcinoma patients treated with immune checkpoint inhibitors and tyrosine kinase inhibitors
por: Luo, Ning, et al.
Publicado: (2023)

Phosphorylation in Novel Mitochondrial Creatine Kinase Tyrosine Residues Render Cardioprotection against Hypoxia/Reoxygenation Injury
por: Park, Nammi, et al.
Publicado: (2021)

Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy
por: Chen, Zhuxing, et al.
Publicado: (2022)

Potential prognostic roles of serum lactate and Creatine kinase levels in poisoned patients
por: Golaghaei, Alireza, et al.
Publicado: (2020)

Latest progress in tyrosine kinase inhibitors
por: Pospelova, Tatiana V., et al.
Publicado: (2014)

Tyrosine kinase inhibitors in sarcoma treatment
por: Kyriazoglou, Anastasios, et al.
Publicado: (2022)

Regulation of T Cell Development and Activation by Creatine Kinase B
por: Zhang, Yafeng, et al.
Publicado: (2009)

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
por: Labots, Mariette, et al.
Publicado: (2016)

Thoracic surgery and COVID-19: changes and managements during the pandemic
por: Wang, Runchen, et al.
Publicado: (2021)

Characteristics of trauma patients with creatine kinase elevation
por: Assanangkornchai, N, et al.
Publicado: (2015)

Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database
por: Xiong, Shan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ddhobhb91vfh8cq2vtmc53nuc